Delivery Order SPE2DB20D3103-SPE2DB25FN2Z8

Award Date 4/3/25
Potential Completion Date 4/4/25
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $1,183.80 firm fixed-price delivery order is for 20 mg dextroamphetamine-amphetamine capsules, without any set-aside designation. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,480.78 firm-fixed-price delivery order is for the supply of 4,566,111,129 units of the drug Dextroamphetamine-Amphetamine 25 mg capsules. The contract has an ultimate completion date of October 16, 2024 and was awarded on October 15, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $1,857.79 firm-fixed-price contract is for the delivery of 20 mg dextroamphetamine-amphetamine capsules. The order has a completion date of May 20, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,898.86 firm fixed price delivery order is for the supply of 4,568,249,769 units of the prescription medication Dextroamphetamine-Amphetamine 20 mg capsules. The contract has an ultimate completion date of May 15, 2025 and is not set aside for any specific business type. AmerisourceBergen Drug...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of dextroamphetamine-amphetamine 20 mg capsules. The $2,665.48 firm-fixed price delivery order has a completion date of May 27, 2025 and is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,243.38 firm fixed-price delivery order is for the supply of 4,568,254,602 tablets of the prescription medication dextroamphetamine-amphetamine 10 mg. The contract has an ultimate completion date of May 15, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 20 mg dextroamphetamine-amphetamine capsules. The $3,884.60 contract has an ultimate completion date of April 24, 2025 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,237.89, is a Firm Fixed Price Delivery Order to provide 4,567,886,472 units of the prescription drug dextroamphetamine-amphetamine 10 mg capsules. The award has an ultimate completion date of April 14, 2025. This contract is not associated with a set-aside designation. Amerisourcebergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,223.15 firm fixed price delivery order is for 100 units of the prescription medication Dextroamphetamine-Amphetamine 10 mg capsules. The contract has an ultimate completion date of June 18, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $1,033.56 firm fixed-price delivery order is for the supply of dextroamphetamine-amphetamine 20 mg capsules, a prescription medication. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB25FN2Z8
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,058.45 firm fixed-price delivery order is for 100 capsules of the prescription drug dextroamphetamine-amphetamine 20 mg. The contract has an ultimate completion date of April 4, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This award is not designated with a set-aside.

Generated 7/3/25, 3:08 PM